Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 5/20 | 0.51 |
| ▸ | ADORA1 | P30542 | 3/20 | 0.51 |
| ▸ | PI4KA | P42356 | 4/20 | 0.47 |
| ▸ | PI4K2B | Q8TCG2 | 4/20 | 0.47 |
| ▸ | PI4K2A | Q9BTU6 | 4/20 | 0.47 |
| ▸ | PI4KB | Q9UBF8 | 4/20 | 0.47 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.47 |
| ▸ | AHCY | P23526 | 5/20 | 0.47 |
| ▸ | GSK3B | P49841 | 1/20 | 0.45 |
| ▸ | EGFR | P00533 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL887808 | 0.79 | ADORA2A (0.59) | ADORA2AADORA1PI4KAPI4K2BPI4K2A | |
| SCHEMBL385843 | 0.79 | ADORA2A (0.55) | ADORA2AADORA1PI4KAPI4K2BPI4K2A | |
| SCHEMBL2698569 | 0.78 | ADORA2A (0.50) | ADORA2AADORA1PI4KAPI4K2BPI4K2A | |
| SCHEMBL16485904 | 0.78 | GSK3B (0.48) | ADORA2AADORA1PI4KAPI4K2BPI4K2A | |
| SCHEMBL5663802 | 0.76 | ADORA2A (0.51) | ADORA2AADORA1PI4KAPI4K2BPI4K2A | |
| SCHEMBL283730 | 0.76 | FGFR1 (0.51) | ADORA2AADORA1PI4KAPI4K2BPI4K2A | |
| SCHEMBL28296105 | 0.76 | ADORA2A (0.47) | ADORA2AADORA1PI4KAPI4K2BPI4K2A | |
| SCHEMBL14125909 | 0.76 | ADORA2A (0.51) | ADORA2AADORA1PI4KAPI4K2BPI4K2A | |
| SCHEMBL27592464 | 0.75 | KDM4E (0.55) | ADORA2AADORA1PI4KAPI4K2BPI4K2A | |
| SCHEMBL29254213 | 0.74 | ADORA2A (0.48) | ADORA2AADORA1PI4KAPI4K2BPI4K2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 105 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4370665-A1 | COMPOSITIONS, METHODS, AND SYSTEMS FOR ENHANCED DNA TRANSFORMATION IN BACTERIA | North Carolina State University (US) | 2024-05-22 | — | — | EP | disclosed |
| US-20240117413-A1 | SEQUENCING BY EMERGENCE | XGENOMES CORP (US) | 2024-04-11 | — | — | US | disclosed |
| CN-117441014-A | Enzyme composition having at least two different thermostable polypeptides having type II DNA methyltransferase activity | 布鲁克生物科技公司 | 2024-01-23 | — | — | CN | disclosed |
| CN-117441014-A | Enzyme composition having at least two different thermostable polypeptides having type II DNA methyltransferase activity | 布鲁克生物科技公司 | 2024-01-23 | — | — | CN | disclosed |
| CN-116426627-A | M based on MTR mRNA 6 Method for evaluating repeated spontaneous abortion risk through A methylation modification and application thereof | 河南省人民医院 | 2023-07-14 | — | — | CN | disclosed |
| WO-2023122744-A1 | METHYLTRANSFERASE APPLICATION FOR EVALUATING THE METHYLATION STATUS OF A POLYNUCLEOTIDE | APR BIOSCIENCES INC. (US) | 2023-06-29 | — | — | WO | disclosed |
| WO-2023288250-A1 | COMPOSITIONS, METHODS, AND SYSTEMS FOR ENHANCED DNA TRANSFORMATION IN BACTERIA | NORTH CAROLINA STATE UNIVERSITY (US) | 2023-01-19 | — | — | WO | disclosed |
| US-20220359040-A1 | SYSTEMS AND METHODS FOR DETERMINING SEQUENCE | XGENOMES CORP. | 2022-11-10 | — | — | US | disclosed |
| CN-112730554-B | Electrode, preparation of biosensor containing electrode and application of electrode in detection of methyltransferase | 山东师范大学 | 2022-09-09 | — | — | CN | disclosed |
| EP-4010473-A1 | COMPOSITIONS AND METHODS FOR DETECTING METHYLATED DNA | Battelle Memorial Institute (US) | 2022-06-15 | — | — | EP | disclosed |
| US-5208157-A | Cloning the TaqI restriction and modification genes | NEW ENGLAND BIOLABS, INC. (US) | 1993-05-04 | — | — | US | disclosed |
| US-5198354-A | Genetic engineering | NEW ENGLAND BIOLABS, INC. (US) | 1993-03-30 | — | — | US | disclosed |
| US-5196331-A | Genetic engineering | NEW ENGLAND BIOLABS, INC. (US) | 1993-03-23 | — | — | US | disclosed |
| US-5196332-A | HAE-Haemophilus aegyptius | NEW ENGLAND BIOLABS, INC. (US) | 1993-03-23 | — | — | US | disclosed |
| US-5180673-A | Cloning restriction and modification genes | NEW ENGLAND BIOLABS, INC. (US) | 1993-01-19 | — | — | US | disclosed |
| US-5137823-A | METHOD FOR PRODUCING THE BAMHI RESTRICTION ENDONUCLEASE AND METHYLASE | NEW ENGLAND BIOLABS, INC. (US) | 1992-08-11 | — | — | US | disclosed |
| EP-0428572-A1 | PRODUCING COMMERCIALLY VALUABLE POLYPEPTIDES WITH GENETICALLY TRANSFORMED ENDOSPERM TISSUE | WASHINGTON UNIVERSITY SCHOOL OF MEDICINE (US) | 1991-05-29 | — | — | EP | disclosed |
| WO-1990001551-A1 | PRODUCING COMMERCIALLY VALUABLE POLYPEPTIDES WITH GENETICALLY TRANSFORMED ENDOSPERM TISSUE | WASHINGTON UNIVERSITY SCHOOL OF MEDICINE (US) | 1990-02-22 | — | — | WO | disclosed |
| EP-0248678-A2 | Method for cloning restriction modification system | NEW ENGLAND BIOLABS, INC. (US) | 1987-12-09 | — | — | EP | disclosed |
| EP-0193413-A2 | Cloning restriction and modification genes | NEW ENGLAND BIOLABS, INC. (US) | 1986-09-03 | — | — | EP | disclosed |